In the general Scottish breast cancer population aged 50 to 69, the lowest crude 5-year breast cancer specific survival (95% CI), regardless of diabetes status, was observed among women with TNBC tumours at 78.6 compared to 81.7 for HER2-enriched tumours and 95.5% for luminal A tumours27. This evidence concerns the gene ERBB2 and neoplasm.